IMAGENETIX, INC. (OTCBB: IAGX), an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health, issued an informative letter to all shareholders.
The letter detailed that fiscal 2009, the twelve months ended March 31, 2009, was a pivotal year for the company. First, IAGX continued scientific achievements; second, they expanded the distribution of their flag-ship branded product, InflameAway Celadrin(R); and, third, that they will be introducing a new innovative product, BioGuard(TM). In addition, IAGX continues to position their fat loss product. Read More | Learn about IAGX | Corporate Filings
No comments:
Post a Comment